Extent of resection, consequent duodenal food passage reconstruction, and postoperative adjuvant therapy for resectable middle gastric carcinoma with D2 lymph node dissection

Annals of Cancer Research and Therapy

Volumn 10, Issue 1-2, 2002, Pages 45-62

  Nabeshima, Kazuhito ^a   Ogoshi, Kyoji ^a   Okamoto, Yuichi ^a   Morita, Mari ^a   Nakamura, Kenji ^a   Iwata, Kunihiro ^a   Kondoh, Yasumasa ^a   Makuuchi, Hiroyasu ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Duodenal food passage reconstruction; Gastric resection; Middle gastric cancer; Postoperative adjuvant therapy; Stages of cancer

Indexed keywords

FLUOROURACIL; KRESTIN; TEGAFUR; UFT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DUODENUM; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PLASTIC SURGERY; POSTOPERATIVE CARE; PROGNOSIS; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; SURGEON; SURGICAL TECHNIQUE;

EID: 5044223165     PISSN: 13446835     EISSN: None     Source Type: Journal    
DOI: 10.4993/acrt1992.10.45     Document Type: Article

References (20)

1. Bozzetti, F., Marubini, E., Bonfanti, G., Miceli, R., Piano, C. and Gennari, L. (1999). Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann. Surg. 230:170-178.
2. Buhl, K., Lehnert, T., Schlag, P. and Herfarth, C. (1995). Reconstruction after gastrectomy and quality of life. World J. Surg. 19:558-564.
3. Chareton, B., Landen, S., Manganas, D., Meunier, B. and Launois, B. (1996). Prospective randomized trial comparing Billroth I and Billroth II procedures for carcinoma of the gastric antrum. J. Am. Coll. Surg. 183: 190-194.
4. Davies, J., Johnston, D., Sue-Ling, H., Young, S., May, J., Griffith, J., Miller, G and Martin, I. (1998). Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life. World J. Surg. 22:1048-1055.
5. Del Gaudio, A., Marzo, C. (1991). Interposition of the first jejunal loop for reconstruction after total gastrectomy. Int. Surg. 76:91-97.
6. Espat, N.J. and Karpeh, M. (1998). Reconstruction following total gastrectomy: a review and summary of the randomized prospective clinical trials. Surg. Oncol. 7:65-69.
7. Nakamura, K., Ogoshi, K., Okamoto, Y., Nabeshima, K., Morita, M., Iwata, K., Kondoh, Y. and Makuuchi, H. (2002). Postoperative adjuvant therapy is an important factor for surgical management in resecable distal gastric carcinoma with D2 lymph node dissection. Ann. Cancer Res. Ther. 9: ( ).
8. Gennari, L., Bozzetti, F., Bonfanti, G., Morabito, A., Bufalino, R., Doci, R. and Andreola, S. (1986). Subtotal versus total gastrectomy for cancer of the lower two-thirds of the stomach: a new approach to an old problem. Br. J. Surg. 73:534-538.
9. Gouzi, J.L., Huguier, M., Fagniez, P.L., Launois, B., Flamant, Y., Lacaine, F., Paquet, J.C. and May, J.M. (1989). Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. Ann. Surg. 209:162-166.
10. Haugstved, T.K., Viste, A., Eide, G.E. and Soreide, O., Members of the Norwegian Stomach Cancer Trial (1993). Norwegian multi-center study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. Br. J. Surg. 80:475-478.
11. Iwata, K., Ogoshi, K., Tajima, T. and Makuuchi, H. (2000). Long-term consequences of gastrectomy procedures in gastric cancer patients. Ann. Cancer Ther. 8: 97-111.
12. Japanese Research Society for Gastric Cancer (1984). The general rules for the gastric cancer study in surgery and pathology. Part II: Histological classification of gastric cancer. Jpn. J. Surg. 11:140-145.
13. Jentschura, D., Winkler, M., Strohmeier, N., Rumstadt, B. and Hagmuller, E. (1997). Quality-of-life after curative surgery for gastric cancer: a comparison between total gastrectomy and subtotal gastric resection. Hepatogastroenterology 44:1137-1142.
14. Nakazato, H., Koike, A., Saji, S., Ogawa, N. and Sakamoto, J. (1994). Efficacy of immuno-chemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 343:1122-1126.
15. Ogoshi, K., Satou, H., Isono, K., Mitomi, T., Endoh, M. and Sugita, M. (1995). Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radio-chemotherapy. Am. J. Clin. Oncol. 18: 216-222.
16. Robertson C.S., Chung S.C.S., Woods S.D.S., Griffin S.M., Raimes S.A., Lau J.T.F. and Li A.K.C., (1994). A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann. Surg. 220:176-182.
17. Schwarz, A., Buchler, M., Usinger, K., Rieger, H., Glasbrenner, B., Friess, H., Kunz, R. and Beger, H.G., (1996). Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: prospective randomized clinical study. World J. Surg. 20:60-66.
18. Shiu, M.H., Papacristou, D.N., Kosloff, C. and Eliopoulos, G. (1980). Selection of operative procedure for adenocarcinoma of the midstomach. Ann. Surg. 192: 730-737.
19. Svedlund, J., Sullivan, M., Liedman, B., Lundell, L. and Sjodin, I. 1997). Quality of life after gastrectomy for gastric carcinoma: controlled study of reconstructive procedures. World J. Surg. 21:422-433.
20. UICC (1987). TNM classification of malignant tumors. In: UICC International Union Against Cancer. Edited by Hermanek, P., and Sobin, L.H., Springer-Verlag: Berlin, Heidelberg, New York, London, Paris, Tokyo (pp.43-46).